511509 VIVOBIOT

Vivo Bio Tech Share Price

 

Stock Result Declared

 

Start SIP in VIVOBIOT

Start SIP

Performance

  • Low
  • ₹26
  • High
  • ₹29
  • 52 Week Low
  • ₹25
  • 52 Week High
  • ₹45
  • Open Price₹29
  • Previous Close₹29
  • Volume13,133
  • 50 DMA₹29.83
  • 100 DMA₹31.50
  • 200 DMA₹33.67

Investment Returns

  • Over 1 Month -7.18%
  • Over 3 Month -14.66%
  • Over 6 Month -23.27%
  • Over 1 Year -27.31%

Smart Investing Starts Here Start SIP with Vivo Bio Tech for Steady Growth!

Invest Now

Vivo Bio Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 10.2
  • PEG Ratio
  • -0.3
  • Market Cap Cr
  • 46
  • P/B Ratio
  • 0.5
  • Average True Range
  • 1.85
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.53
  • RSI
  • 44.88
  • MFI
  • 46.68

Vivo Bio Tech Financials

Vivo Bio Tech Technicals

EMA & SMA

Current Price
₹28.46
-0.11 (-0.39%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹28.79
  • 50 Day
  • ₹29.83
  • 100 Day
  • ₹31.50
  • 200 Day
  • ₹33.67

Resistance and Support

27.79 Pivot Speed
  • R3 32.58
  • R2 30.78
  • R1 29.59
  • S1 26.60
  • S2 24.80
  • S3 23.61

Vivo Bio Tech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results
2025-08-12 Quarterly Results
2025-05-19 Audited Results
2025-01-09 Quarterly Results

Vivo Bio Tech F&O

Vivo Bio Tech Shareholding Pattern

35.16%
32.7%
32.14%

Vivo Bio Tech FAQs

Vivo Bio Tech share price is ₹28 As on 16 February, 2026 | 04:43

The Market Cap of Vivo Bio Tech is ₹45.9 Cr As on 16 February, 2026 | 04:43

The P/E ratio of Vivo Bio Tech is 10.2 As on 16 February, 2026 | 04:43

The PB ratio of Vivo Bio Tech is 0.5 As on 16 February, 2026 | 04:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23